Related Experiment Video
Updated: Jul 6, 2026

10:59
Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
Published on: November 18, 2013
18.1K
DUT (p.Y116C)-Mutation-Induced Thrombocytopenia in Rabbits
Mengmeng Fang1, Shujun Yang1, Ruonan Liu1
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, and College of Veterinary Medicine, Jilin University, Changchun 130062, China.
International Journal of Molecular Sciences
|May 14, 2025
Summary
Researchers developed a new rabbit model for thrombocytopenia using base editing to study DUT mutations. This model reveals DUT
Area of Science:
- Hematology
- Genetics
- Mitochondrial Biology
Background:
- Thrombocytopenia is a condition of low platelet counts.
- Mutations in the DUT gene are linked to bone marrow failure and diabetes mellitus syndrome (BMFDMS), often causing thrombocytopenia.
Purpose of the Study:
- To establish a novel rabbit model for thrombocytopenia using base editing targeting the DUT gene.
- To investigate the mechanisms underlying DUT mutation-associated thrombocytopenia and its impact on platelet function.
Main Methods:
- Generation of a rabbit model with the DUT c.3020A>G (p.Y116C) mutation using SpRY-ABEmax base editing.
- Phenotypic analysis of mutant rabbits, including platelet counts, megakaryocyte numbers, and survival rates.
- Mechanistic studies on mitochondrial structure/function and mitophagy in platelets.
Main Results:
- The DUT (p.Y116C) mutation model accurately recapitulates human thrombocytopenia.
- Mutant rabbits showed reduced megakaryocyte numbers, platelet counts, and survival.
- DUT mutation caused mitochondrial dysfunction and enhanced mitophagy in platelets, potentially via the Park2 pathway.
Conclusions:
- This study presents the first genetic rabbit model for DUT (p.Y116C) mutation-associated thrombocytopenia.
- Findings provide insights into DUT's role in platelet production and function.
- The model highlights potential therapeutic targets for human thrombocytopenia.

